Scenario and Experience Are Key to Implementing AI-Powered Comprehensive Cancer Care Management

“In 2024, Meet Health officially entered the 3.0 phase, leveraging AI to empower whole-course management for cancer patients.”

On the morning of May 10, at the Health Insurance and Health Management Innovation Development Forum held during the 9th Future Healthcare Top 100 Exhibition organized by VCBeat, Liu Wengui, Founder and Chairman of Meet Health, delivered a keynote address titled “Opportunities in Whole-Course Cancer Care Management Amid the New Wave of Artificial Intelligence.” He formally signaled to the industry that, building upon its accumulated experience and resources in whole-course cancer care management, as well as its precise grasp of industry trends and deep insights into the needs of cancer patients and their families, Meet Health has once again achieved self-iteration, propelling whole-course cancer care management fully into the era of digital intelligence.

Liu Wengui’s presentation was met with an enthusiastic response, attracting numerous companies across the oncology rehabilitation ecosystem to seek in-depth collaboration. At the forum, VCBeat had the opportunity to engage in a face-to-face dialogue with Liu Wengui, who elaborated on the future trends of whole-course cancer management in the new wave of artificial intelligence, as well as the vertical ecosystem scenarios and underlying strategic considerations of Meet Health 3.0.

Meet Health: This name is by no means unfamiliar to those well-versed in the management of oncology patients in China.

Meet Health is the leading oncology patient platform in China by scale. Since its establishment in 2015, it has not only attracted over 2.6 million oncology patients but also forged robust partnerships with numerous multinational pharmaceutical companies, renowned insurance institutions, and other ecosystem partners. In recent years, Meet Health has been appointed as the Deputy Secretary-General Unit of the Rehabilitation Branch of the China Anti-Cancer Association (CACA), a member unit of the Media Communication Working Committee of CACA, a committee member unit of the Patient Behavior Management Subcommittee of the China Association for Promotion and Education, and a member of the Union for International Cancer Control (UICC). These affiliations underscore the platform’s significant influence.

andThroughout every stage of Meet Health’s development, the patient-centric philosophy of addressing patients’ actual needs has remained consistent.This, perhaps, is the reason why Meet Health has become China's leading whole-course management platform for cancer patients.

Specifically,From 2015 to 2019, during the Meet Health 1.0 phase, the company primarily adopted two approaches—patient community and patient education—to address information asymmetry among cancer patients through peer support and professional science popularization content, thereby alleviating patient anxiety and assisting them in participating in treatment decision-making.

In terms of peer support among patients, Meet Health has established a cancer patient organization with a leading national scale in China, bringing together over 2.6 million precisely targeted oncology patients. Its user-friendly interactive design not only boosts community engagement among patients but also delivers clinical and emotional value. In 2023 and 2024, Meet Health was consecutively recognized as a National Excellent Demonstration Cancer Patient Organization.

In terms of science popularization, Meet Health has established robust capabilities and accumulated extensive resources. Specifically, regarding content production, Meet Health has formed a multidisciplinary team with professional backgrounds in medicine, pharmacy, journalism, and related fields, enabling the continuous output of high-quality educational content for patients. In terms of delivery methods, Meet Health meets patients’ diverse information needs through multiple channels, including illustrated articles, videos, live-streamed lectures, patient education sessions, and patient stories. Furthermore, in the realm of targeted science popularization, Meet Health has implemented a vertical disease-specific strategy, providing precise educational content for specific conditions such as breast cancer, lung cancer, gynecological tumors, gastric cancer, liver cancer, colorectal cancer, urological tumors, and hematologic malignancies. In summary, Meet Health’s patient education initiatives are characterized by professional content, diverse formats, and highly specialized, precise targeting.

By continuously expanding its patient base and deepening engagement with this community, Meet Health has identified a significant surge in demand for medical consultations and pharmaceutical services among cancer patients, beyond their need for professional knowledge and information. In response, during its 2.0 phase from 2020 to 2023, Meet Health focused on expanding its medical and pharmaceutical resources by launching an internet hospital and establishing partnerships with over 1,200 oncologists and rehabilitation institutions across China.

Furthermore, Meet Health fully recognizes the critical importance of payment solutions in the treatment and rehabilitation of oncology patients. To this end, it is actively collaborating with numerous insurance institutions to build a closed-loop ecosystem integrating oncology pharmaceuticals and insurance. This initiative aims to provide patients with higher-quality medical and pharmaceutical services while simultaneously alleviating their financial burden.Notably, in its collaborations with insurance companies, Meet Health has not only helped patients match the most suitable insurance products to build financial leverage for long-term rehabilitation but also been deeply involved in the product design of health insurance. Since participating in the design of China’s first health insurance product for breast cancer patients with pre-existing conditions in late 2018, Meet Health has partnered with nine domestic insurers to develop more than 20 health insurance products tailored for individuals with pre-existing conditions.

It is also worth noting that during the 2.0 phase, Meet Health gradually established a closed-loop ecosystem through its resource linkages. With the rise of the concept of whole-course cancer management, Meet Health has been focusing on connecting medical and pharmaceutical resources covering pre-diagnosis prevention, intra-diagnosis treatment, and post-diagnosis management, thereby truly implementing the philosophy of whole-course cancer management.

Thus, Meet Health has established a trinity-based comprehensive cancer care management system integrating media (science popularization and patient education), social networking (peer support among patients), and medical services. In 2024, Meet Health embarked on a new journey, initiating its evolution into the 3.0 phase.

Meet Health 3.0, Highly Integrated with Artificial Intelligence

As early as September 2022, Meet Health initiated the exploration and application of artificial intelligence technologies. From the PMAS (Patient Management Assistance System), which supports health management teams in delivering refined patient care, to the AIGC-powered intelligent content generation system that assists medical editors in producing oncology-related popular science content, and further to the AI-driven Patient Insight System that leverages big data analytics on real patient chat interactions to generate patient insight reports, Meet Health has achieved notable results in empowering its internal operations through artificial intelligence.

andMeet Health’s Explorations and Practices in Artificial Intelligence from 2025 to Present Have Primarily Focused on the Patient Interface, Continuing to Emphasize a Patient-Centric Approach, Consistent with Its Previous Phase 1.0 and Phase 2.0 Stages.

How Can We Concretely Understand “Patient-Centered Care”? In an interview, VCBeat raised this question, and Liu Wengui’s response revolved around two key concepts: scenarios and experience. While the importance of experience is self-evident, the notion of scenarios implicitly addresses the need to resolve patients’ practical needs.

From the AI Rehabilitation Assistant launched by Meet Health in January this year, we can glimpse how Meet Health 3.0 leverages artificial intelligence to address the needs of cancer patients by focusing on scenarios and user experience.

AI Rehabilitation Assistant is an oncology rehabilitation management tool designed to provide cancer patients with answers to their questions, disease course management, and rehabilitation guidance throughout the anti-cancer process. It primarily features three core functions: AI Assistant, Rehabilitation Records, and Patient Peer Support. Among these, the AI Assistant offers four services: report interpretation, diagnostic and treatment Q&A, clinical guideline queries, and medication information lookup.In other words, report interpretation, diagnosis and treatment Q&A, guideline queries, and medication inquiries are the primary scenarios for Meet Health’s exploration of AI technology applications in patient-facing services.

The underlying reasons are linked to the patient needs identified by Meet Health. According to the “2025 Survey on the Current Use of AI Tools in Cancer Care Management” released by Meet Health, the top three issues patients seek to address using AI tools are consultation and diagnostic Q&A, interpretation of medical reports, and drug information queries. Specifically, consultation and diagnostic Q&A accounted for 66.07%, interpretation of medical reports for 64.29%, and drug information queries for 55.36%. The inclusion of clinical guideline search functionality stems from Meet Health’s observation that cancer patients have demonstrated an increasingly pronounced trend toward specialization in recent years.

“In the past, many cancer patients were not even aware of what clinical guidelines were. However, in recent years, cancer patients have demonstrated a growing enthusiasm for learning about these guidelines, as this knowledge helps them better understand their treatment plans and enables them to participate more deeply in diagnostic and therapeutic decision-making,” said Liu Wengui.

So, what advantages does the Meet Health AI Rehabilitation Assistant have over common AI Q&A products on the market? In response, Liu Wengui stated that the advantage of the Meet Health AI Rehabilitation Assistant lies in its deep understanding of cancer patients’ needs developed over ten years of growth, as well as its proprietary oncology medical knowledge base. This enables it to enhance the professionalism and accuracy of its responses while better meeting patients’ personalized needs.

Furthermore,On March 25 this year, Meet Health’s “Method and System for Managing Medication Side Effects in Cancer Patients Based on Big Data Analysis” was officially granted a patent by the China National Intellectual Property Administration. Prior to this, Meet Health’s independently developed medical AI algorithm had successfully passed the filing process with the Algorithm Filing System of the Cyberspace Administration of China. This demonstrates that the Meet Health AI Assistant has met national-level standards in terms of technical compliance, medical professionalism, and user privacy protection.

According to Liu Wengui, the Meet Health AI Rehabilitation Assistant is currently in its early stages and will be gradually rolled out to patients in a phased manner. During this process, the service experience will be continuously optimized, with full availability expected by the end of the year.

In the Meet Health 3.0 phase, it remains highly relevant to physicians.

According to Liu Wengui, Meet Health has been intensifying its efforts to deepen collaborations with physicians in recent years. This is because, on the one hand, physicians play a crucial role in the whole-course management of cancer; on the other hand, through years of accumulation, Meet Health has developed the resources and capabilities to empower physicians.

Specifically,In Phase 3.0, Meet Health will collaborate closely with physicians to focus on two key areas of partnership: first, collaborations in patient education and the development of physicians’ professional brands (IP); second, collaborations related to research projects and industry white papers.The former primarily leverages Meet Health’s established content production capabilities, media matrix resources, and patient base accumulated through prior science popularization and patient education efforts; the latter is built upon Meet Health’s patient resources as well as its medical and pharmaceutical industry connections.However, it must be emphasized that, regardless of the form of collaboration, Meet Health’s ultimate goal is to provide cancer patients with higher-quality, more professional whole-course disease management services.

Through science popularization and patient education, cancer patients and their families (potential at-risk populations) can enhance their awareness of early screening and diagnosis, improve their understanding of the disease, adopt a scientific approach to managing it, and alleviate anxiety; meanwhile, physicians can reach a broader patient base. Furthermore, collaboration on research projects and industry white papers not only elevates physicians’ diagnostic and therapeutic capabilities and supports their professional growth, but also promotes standardization of care while advancing overall treatment standards, thereby providing patients with up-to-date, comprehensive whole-course cancer management. In other words, within the ecosystem built by Meet Health, both physicians and patients benefit mutually.

At the same time, Meet Health also recognizes that the evolving needs of cancer patients will never cease. This also means that Meet Health’s upgrades and iterations will never stop. Regarding the future of cancer patient management, Liu Wengui stated that, given that artificial intelligence technology can enhance the collaborative efficiency of the whole-course cancer care management system and further improve the precision and personalization level of whole-course cancer care management, therefore,The future of whole-course management for cancer patients will undoubtedly be driven by AI-powered digital intelligence. Meet Health is also committed to actively and comprehensively embracing artificial intelligence technologies, building a patient-centered ecosystem for whole-course cancer management driven by AI-powered digital intelligence.

And,Liu Wengui emphasized that only by achieving excellence in specific scenarios can we provide a better experience and, consequently, develop a more sustainable business model. Moreover, offering seamless disease management services in out-of-hospital settings will present greater opportunities.